NALBUPHIN OrPha sol inj 20 mg/2ml 10 amp 2 ml

7680569890026 CH-56989 N02AF02 01.01.3.
NALBUPHIN OrPha sol inj 20 mg/2ml 10 amp 2 ml
NALBUPHIN OrPha sol inj 20 mg/2ml 10 amp 2 ml
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
5698901
CPT
-
Packaging group
10 x 2
Unit
ml
Composition
nalbuphini hydrochloridum 20 mg, natrii chloridum, acidum citricum, natrii citras dihydricus, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 2 ml corresp. natrium 1.64 mg.

Articles (1)

Nalbuphin OrPha, Injektionslösung
Injektionslösung
10 x 2
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
13/11/2024
Professional SmPC
Français
13/11/2024
Professional SmPC
Italien
13/11/2024

Detailed composition

Substance Quantity Type Category
nalbuphini hydrochloridum
20.0 MG Substance Wirkstoff (Principe actif)
natrii chloridum
- Substance HNIDK
acidum citricum
- Substance HNIDK
natrii citras dihydricus
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
1.64 MG Substance HBESI

Authorization holder

OrPha Swiss GmbH

8700 Küsnacht ZH

Authorization information

Swissmedic authorization number
56989
Drug name
Nalbuphin OrPha, Injektionslösung
Galenic form
LSINJ
ATC Code
N02AF02
Authorization status
Z
Dispensation category
A
First authorization
15/10/2004
Authorization expiration date
31/12/9999
IT number
01.01.3.
Domain
Human medicine
Field of application
Mittelschwere bis schwere Schmerzen

Packaging details

Description (FR)
NALBUPHIN OrPha sol inj 20 mg/2ml 10 amp 2 ml
Description (DE)
NALBUPHIN OrPha Inj Lös 20 mg/2ml 10 Amp 2 ml
Market launch
15/10/2004
Narcotic (BTM)
No
Buy us a coffee Explore the data